The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
CD73: a potent suppressor of antitumor immune responses
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Self-citationIpilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
Self-citationAdaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
Self-citationAdenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
Robson, S. C., Sévigny, J., & Zimmermann, H. (2006) · Purinergic Signalling · doi:10.1007/s11302-006-9003-5 · Cited by 932
Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 813
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N. A., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15337 · Cited by 679
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215337 · Cited by 660
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572
Self-citationExtracellular adenosine triphosphate and adenosine in cancer
Stagg, J., & Smyth, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.292 · Cited by 571
Self-citationCancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
Clayton, A., Al-Taei, S., Webber, J., Mason, M. D., & Tabi, Z. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003884 · Cited by 540
Zarek, P. E., Huang, C.-T., Lutz, E. R., Kowalski, J., Horton, M. R., Linden, J., Drake, C. G., & Powell, J. D. (2008) · Blood · doi:10.1182/blood-2007-03-081646 · Cited by 515
Haskó, G., Kuhel, D. G., Chen, J.-F., Schwarzschild, M. A., Deitch, E. A., Mabley, J. G., Marton, A., & Szabó, C. (2000) · The FASEB Journal · doi:10.1096/fj.99-0508com · Cited by 512
Physiological roles for ecto-5’-nucleotidase (CD73)
Colgan, S. P., Eltzschig, H. K., Eckle, T., & Thompson, L. F. (2006) · Purinergic Signalling · doi:10.1007/s11302-005-5302-5 · Cited by 500
NT5E Mutations and Arterial Calcifications
St. Hilaire, C., Ziegler, S. G., Markello, T. C., Brusco, A., Groden, C., Gill, F., Carlson-Donohoe, H., Lederman, R. J., Chen, M. Y., Yang, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0912923 · Cited by 455
Jin, D., Fan, J., Wang, L., Thompson, L. F., Liu, A., Daniel, B. J., Shin, T., Curiel, T. J., & Zhang, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3109 · Cited by 432
Adenosine receptors in regulation of dendritic cell differentiation and function
Novitskiy, S. V., Ryzhov, S., Zaynagetdinov, R., Goldstein, A. E., Huang, Y., Tikhomirov, O. Y., Blackburn, M. R., Biaggioni, I., Carbone, D. P., Feoktistov, I., et al. (2008) · Blood · doi:10.1182/blood-2008-02-136325 · Cited by 430
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
Stagg, J., Divisekera, U., Duret, H., Sparwasser, T., Teng, M. W. L., Darcy, P. K., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4246 · Cited by 401
Self-citationMandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047423 · Cited by 390
Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
Aymeric, L., Apetoh, L., Ghiringhelli, F., Tesniere, A., Martins, I., Kroemer, G., Smyth, M. J., & Zitvogel, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3566 · Cited by 380
Self-citationAdenosine promotes alternative macrophage activation via A2A and A2B receptors
Csóka, B., Selmeczy, Z., Koscsó, B., Németh, Z. H., Pacher, P., Murray, P. J., Kepka‐Lenhart, D., Jr., S. M. M., Gause, W. C., Leibovich, S. J., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-190934 · Cited by 376
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Mattarollo, S. R., Loi, S., Duret, H., Ma, Y., Zitvogel, L., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0753 · Cited by 333
Self-citationNew markers for minimal residual disease detection in acute lymphoblastic leukemia
Coustan-Smith, E., Song, G., Clark, C., Key, L., Liu, P., Mehrpooya, M., Stow, P., Su, X., Shurtleff, S., Pui, C.-H., et al. (2011) · Blood · doi:10.1182/blood-2010-12-324004 · Cited by 323
Terabe, M., Swann, J., Ambrosino, E., Sinha, P., Takaku, S., Hayakawa, Y., Godfrey, D. I., Ostrand-Rosenberg, S., Smyth, M. J., & Berzofsky, J. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051381 · Cited by 283
Self-citationSun, X., Wu, Y., Gao, W., Enjyoji, K., Csizmadia, E., Müller, C. E., Murakami, T., & Robson, S. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.007 · Cited by 279
Chemotherapy induces ATP release from tumor cells
Martins, I., Tesniere, A., Kepp, O., Michaud, M., Schlemmer, F., Senovilla, L., Séror, C., Métivier, D., Perfettini, J.-L., Zitvogel, L., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.22.10026 · Cited by 278
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
Wang, L., Fan, J., Thompson, L. F., Zhang, Y., Shin, T., Curiel, T. J., & Zhang, B. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45559 · Cited by 262
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Ryzhov, S., Novitskiy, S. V., Goldstein, A. E., Biktasova, A., Blackburn, M. R., Biaggioni, I., Dikov, M. M., & Feoktistov, I. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101225 · Cited by 261
Hoskin, D., Mader, J., Furlong, S., Conrad, D., & Blay, J. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.527 · Cited by 242
Panther, E., Corinti, S., Idzko, M., Herouy, Y., Napp, M., la Sala, A., Girolomoni, G., & Norgauer, J. (2003) · Blood · doi:10.1182/blood-2002-07-2113 · Cited by 229
Ohta, A., Ohta, A., Madasu, M., Kini, R., Subramanian, M., Goel, N., & Sitkovsky, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901247 · Cited by 215
CD73-Deficient Mice Are Resistant to Carcinogenesis
Stagg, J., Beavis, P. A., Divisekera, U., Liu, M. C. P., Möller, A., Darcy, P. K., & Smyth, M. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0420 · Cited by 211
Self-citationCsóka, B., Németh, Z. H., Virág, L., Gergely, P., Leibovich, S. J., Pacher, P., Sun, C.-X., Blackburn, M. R., Vizi, E. S., Deitch, E. A., et al. (2007) · Blood · doi:10.1182/blood-2007-01-065870 · Cited by 204
Adenosine and cAMP are potent inhibitors of the NF‐κB pathway downstream of immunoreceptors
Minguet, S., Huber, M., Rosenkranz, L., Schamel, W. W. A., Reth, M., & Brummer, T. (2005) · European Journal of Immunology · doi:10.1002/eji.200425524 · Cited by 197
Kreckler, L. M., Wan, T. C., Ge, Z.-D., & Auchampach, J. A. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096016 · Cited by 196
Häusler, S. F. M., Montalbán del Barrio, I., Strohschein, J., Anoop Chandran, P., Engel, J. B., Hönig, A., Ossadnik, M., Horn, E., Fischer, B., Krockenberger, M., et al. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1040-4 · Cited by 193
Chemotherapy and radiotherapy: Cryptic anticancer vaccines
Ma, Y., Kepp, O., Ghiringhelli, F., Apetoh, L., Aymeric, L., Locher, C., Tesniere, A., Martins, I., Ly, A., Haynes, N. M., et al. (2010) · Seminars in Immunology · doi:10.1016/j.smim.2010.03.001 · Cited by 193
Self-citationSchnurr, M., Toy, T., Shin, A., Hartmann, G., Rothenfusser, S., Soellner, J., Davis, I. D., Cebon, J., & Maraskovsky, E. (2004) · Blood · doi:10.1182/blood-2003-06-1959 · Cited by 188
Mandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Lenzner, D. E., Jackson, E. K., Gorelik, E., Lang, S., Johnson, J. T., & Whiteside, T. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1143 · Cited by 182
Alternative activation of tumor-associated macrophages by IL-4: Priming for protumoral functions
Wang, H.-W., & Joyce, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.24.14322 · Cited by 177
Generation of anti‐inflammatory adenosine byleukocytes is regulated by TGF‐β
Regateiro, F. S., Howie, D., Nolan, K. F., Agorogiannis, E. I., Greaves, D. R., Cobbold, S. P., & Waldmann, H. (2011) · European Journal of Immunology · doi:10.1002/eji.201141512 · Cited by 166
Romio, M., Reinbeck, B., Bongardt, S., Hüls, S., Burghoff, S., & Schrader, J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00385.2010 · Cited by 158
Altered purinergic signaling in CD73‐deficient mice inhibits tumor progression
Yegutkin, G. G., Marttila‐Ichihara, F., Karikoski, M., Niemelä, J., Laurila, J. P., Elima, K., Jalkanen, S., & Salmi, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041292 · Cited by 156
Improving cancer immunotherapy by targeting tumor-induced immune suppression
Stewart, T. J., & Smyth, M. J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9280-5 · Cited by 156
Self-citationCD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation
Zernecke, A., Bidzhekov, K., Özüyaman, B., Fraemohs, L., Liehn, E. A., Lüscher‐Firzlaff, J., Lüscher, B., Schrader, J., & Weber, C. (2006) · Circulation · doi:10.1161/circulationaha.105.595249 · Cited by 147
Fukuda, K., Sakakura, C., Miyagawa, K., Kuriu, Y., Kin, S., Nakase, Y., Hagiwara, A., Mitsufuji, S., Okazaki, Y., Hayashizaki, Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602187 · Cited by 144
Serra, S., Horenstein, A. L., Vaisitti, T., Brusa, D., Rossi, D., Laurenti, L., D'Arena, G. F., Coscia, M., Tripodo, C., Inghirami, G., et al. (2011) · Blood · doi:10.1182/blood-2011-08-374728 · Cited by 142
The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells
Wilson, J. M., Ross, W. G., Agbai, O. N., Frazier, R., Figler, R. A., Rieger, J. M., Linden, J. M., & Ernst, P. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801279 · Cited by 135
The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation
Bavaresco, L., Bernardi, A., Braganhol, E., Cappellari, A. R., Rockenbach, L., Farias, P. F., Wink, M. R., Cañedo, A. D., & Battastini, A. M. O. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9877-3 · Cited by 133
Expression of A2B adenosine receptors in human lymphocytes: Their role in T cell activation
Mirabet, M., Herrera, C., Cordero, O. J., Mallol, J., Lluís, C., & Franco, R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.4.491 · Cited by 128
Leth‐Larsen, R., Lund, R. R., Hansen, H. V., Lænkholm, A., Tarin, D., Jensen, O. N., & Ditzel, H. J. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800061-mcp200 · Cited by 119
Ryzhov, S. V., Zaynagetdinov, R., Goldstein, A. E., Novitskiy, S. V., Blackburn, M. R., Biaggioni, I., & Feoktistov, I. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131540 · Cited by 114
Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma
Sądej, R., Spychała, J., & Składanowski, A. C. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000215030.69823.11 · Cited by 106
The Contrasting Roles of NKT Cells in Tumor Immunity
Berzofsky, J. A., & Terabe, M. (2009) · Current Molecular Medicine · doi:10.2174/156652409788970706 · Cited by 103
The A2B Adenosine Receptor Promotes Th17 Differentiation via Stimulation of Dendritic Cell IL-6
Wilson, J. M., Kurtz, C. C., Black, S. G., Ross, W. G., Alam, M. S., Linden, J. M., & Ernst, P. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100117 · Cited by 97
Expression of A3 Adenosine Receptors in Human Lymphocytes: Up-Regulation in T Cell Activation
Gessi, S., Varani, K., Merighi, S., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.711 · Cited by 91
Differential ectonucleotidase expression in human bladder cancer cell lines
Stella, J., Bavaresco, L., Braganhol, E., Rockenbach, L., Farias, P. F., Wink, M. R., Azambuja, A. A., Barrios, C. H., Morrone, F. B., & Battastini, A. M. O. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.01.035 · Cited by 90
Niemelä, J., Henttinen, T. A., Yegutkin, G. G., Airas, L. M., Kujari, A.-M., Rajala, P., & Jalkanen, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1646 · Cited by 86
Ecto‐ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas
Dzhandzhugazyan, K. N., Kirkin, A. F., Straten, P. T., & Zeuthen, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00603-6 · Cited by 86
Spychała, J., & Kitajewski, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.11.001 · Cited by 86
Airas, L. M., Niemelä, J., & Jalkanen, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5411 · Cited by 84
Lukashev, D. E., Smith, P. T., Caldwell, C. C., Ohta, A., Apasov, S. G., & Sitkovsky, M. V. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00158-8 · Cited by 80
The A2aR adenosine receptor controls cytokine production in iNKT cells
Nowak, M. A., Lynch, L., Yue, S. C., Ohta, A., Sitkovsky, M. V., Balk, S. P., & Exley, M. A. (2009) · European Journal of Immunology · doi:10.1002/eji.200939897 · Cited by 79
Savic, V., Stefanović, V., ARDAILLOU, N., et al. (1990) · PubMed · Cited by 68
Different role of CD73 in leukocyte trafficking via blood and lymph vessels
Ålgars, A., Karikoski, M., Yegutkin, G. G., Stoitzner, P., Niemelä, J., Salmi, M., & Jalkanen, S. (2011) · Blood · doi:10.1182/blood-2010-11-321646 · Cited by 68
CD73 Participates in Cellular Multiresistance Program and Protects against TRAIL-Induced Apoptosis
Mikhailov, A., Sokolovskaya, A., Yegutkin, G. G., Amdahl, H., West, A., Yagita∥, H., Lahesmaa, R., Thompson, L. F., Jalkanen, S., Блохин, Д. Ю., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.464 · Cited by 65
Eroglu, A., Canbolat, O., Demirci, S., Kocaoğlu, H., Eryavuz, Y., & Akgül, H. (2000) · Medical Oncology · doi:10.1007/bf02782198 · Cited by 64
Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice
Buchheiser, A., Ebner, A., Burghoff, S., Ding, Z., Romio, M., Viethen, C., Lindecke, A., Köhrer, K., Fischer, J. W., & Schrader, J. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr218 · Cited by 50
NK1.1+ Cells and CD8+ T Cells Mediate the Antitumor Activity of Cl-IB-MECA in a Mouse Melanoma Model
Morello, S., Sorrentino, R., Montinaro, A., Luciano, A., Maiolino, P., Ngkelo, A., Arra, C., Adcock, I. M., & Pinto, A. (2011) · Neoplasia · doi:10.1593/neo.101628 · Cited by 27
Mandapathil, M., & Whiteside, T. L. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.581225 · Cited by 25
Adenosine and IFN-α synergistically increase IFN-γ production of human NK cells
Jeffe, F., Stegmann, K. A., Broelsch, F., Manns, M. P., Cornberg, M., & Wedemeyer, H. H. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108046 · Cited by 17
Effects of Immunomodulators on Ecto‐5′‐Nucleotidase Activity on Blood Mononuclear Cells In Vitro
Christensen, L., ANDERSEN, V., Nygaard, P., et al. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb02875.x · Cited by 12
Cited by
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Self-citationMittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Self-citationCD39 and CD73 in immunity and inflammation
Antonioli, L., Pacher, P., Vizi, E. S., & Haskó, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.005 · Cited by 1,263
Zitvogel, L., Galluzzi, L., Smyth, M. J., & Kroemer, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.014 · Cited by 870
Self-citation
Metadata
- Authors
- Beavis, P. A., Stagg, J., Darcy, P. K., & Smyth, M. J.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 33
- Issue
- 5
- Pages
- 231-237
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W1974409640
- Cited by
- 355
- References
- 77
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.